Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112239436A details a novel Pd-catalyzed bis-carbonylation route for 4-acyl-2(5H)-furanones, offering high yields and streamlined supply chain solutions.
Patent CN102627573B details a high-yield synthesis of 5-aminolevulinic acid hydrochloride using 1,3-dichloroacetone, offering cost reduction and supply chain stability.
Patent CN119874591B details nickel-catalyzed carbonylation for 2-pyrrolidone derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN111423381B details a mild Pd-catalyzed route to 2-trifluoromethyl imidazoles, offering cost reduction in pharmaceutical intermediate manufacturing with high yields.
Novel glucose-based route for trifluoromethyl triazoles offers mild conditions and high efficiency for pharmaceutical intermediate manufacturing.
Novel FeCl3-catalyzed cyclization method offers high yield and cost reduction for pharmaceutical intermediates manufacturing.
Novel binaphthyl phosphoric acid catalyzed synthesis of isoindolinone imines. High yield, mild conditions, suitable for commercial scale-up in pharmaceutical manufacturing.
Patent CN113121462B reveals a metal-free route to 5-trifluoromethyl-1,2,3-triazoles, offering safer manufacturing and cost reduction for pharmaceutical intermediates.
Patent CN110357842B reveals a metal-free route to fluoroalkyl-substituted furans. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity intermediates.
Novel sulfur-promoted method for high-purity triazole intermediates reduces cost and improves supply chain reliability for global pharma manufacturing partners significantly.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing for global supply chains.
Patent CN115286578B reveals a metal-free synthesis for trifluoromethyl pyrazoles. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for quinazolinones, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN113307790B details a metal-free oxidative cyclization for 1,2,4-triazoles. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable methods.
Patent CN112480015B reveals a Pd-catalyzed one-pot method for 2-CF3 quinazolinones, offering cost reduction in API manufacturing and scalable production.
Novel one-step synthesis of pyridazine derivatives via thermal ring contraction. Efficient, metal-free route for API intermediates ensuring high purity and supply continuity.
Patent CN116640121A details a palladium-catalyzed route for trifluoroacetyl indolines, offering cost-effective and scalable solutions for pharmaceutical intermediates manufacturing supply chains.
Novel Rh-catalyzed asymmetric hydrogenation avoids resolution, boosting yield to 42.55% for reliable API intermediate supply.
Novel FeCl3-catalyzed cyclization method offers cost-effective, scalable production of high-purity quinazolinone scaffolds for drug discovery.
Novel metal-free synthesis route for 5-trifluoromethyl-1,2,4-triazoles offers cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains.